C26‐shPla2g7 tumour‐bearing mice developed tumours of similar size as C26‐shCTR tumour‐bearing mice (Figures2A and S4F) and displayed an approximately 75% and 50% reduction in Pla2g7 expression and PAF‐AH activity in tumours, respectively (Figures2B and 2C). Here, PLA2G7 is linked to neoplasm.